AVIC Securities: The pharmaceutical industry's performance in the third quarter is under pressure, with the total market value of heavyweight holdings by funds increasing.

The demand for blood sector in the biological products sector remains strong, with vaccine sales under pressure due to factors such as previous market consumption; the active pharmaceutical ingredient sector is entering the final stage of downstream inventory, showing an improvement in demand, and future performance is expected to gradually improve.

Zhitong FinanceNov 6 21:49 ET

Earnings Miss: Aier Eye Hospital Group Co., Ltd. Missed EPS By 9.1% And Analysts Are Revising Their Forecasts

Simply Wall StNov 1 19:30 ET

Aier Ophthalmology: third quarter report 2024

SZSIOct 30 12:00 ET · Announcements

aier eye hospital group (300015.SZ) released the performance for the first three quarters, with a net income of 3.452 billion yuan, an increase of 8.50%.

Aier Eye Hospital Group (300015.SZ) released the third quarter report for 2024, with revenue for the first three quarters reaching 1...

Zhitong FinanceOct 30 08:14 ET

Express News | Aier Eye Hospital Q3 Net Profit Down 4.6% Y/Y

ReutersOct 30 07:12 ET

Aier Eye Hospital Group (SZSE:300015) Shareholders Have Endured a 44% Loss From Investing in the Stock Three Years Ago

Simply Wall StOct 28 22:42 ET